This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Hansen Medical CEO Discusses Q3 2011 Results - Earnings Call Transcript

Examples of such statements include statements about the potential timing of FDA clearance of our Magellan Robotic System in the U.S. the timing of first cases to be performed with the system, the potential benefit of the system on vascular procedures and the timing of commercializing our Magellan System.

Important factors that could cause actual results to differ materially from those indicated by such forward looking statements include among others engineering regulatory and sales challenges in developing new products and entering new markets, potential safety and regulatory issues that could slow or suspend our sales, the uncertain timelines caused and results of preclinical and clinical trials, the rate of adoption of our systems and the rate of use of our catheters, the scope and validity of intellectual property right applicable to our products, competition from other companies our ability to recruit and retain key personnel, our ability to maintain our remedial actions over previously reported material weaknesses internal control over financial reporting, the effect of credit, financial and economic conditions on capital spending by our potential customers, our ability to manage expenses and obtain additional financing and other risks more fully described in the risk factor section of our quarterly report on Form 10-Q for the quarter ended June 30, 2011 filed with the SEC on our August 8, 2011 and the risks discussed in other reports filed with the SEC.

Given these uncertainties you should not place undue reliance on the forward-looking statements included in our remarks and responses to questions. We undertake no obligation to revise or update information herein to reflect events or circumstance in the future even if new information become available.

And with that I will turn the call over to Hansen Medicals President and CEO Bruce Barclay.

Bruce Barclay

Thanks Pete good afternoon everyone and thank you for joining us today for our third quarter 2011 conference call. I will spend the next several minutes providing an update on the quarter and on recent developments with our new vascular robotic system called the Magellan Robotic System. Pete will then return to provide a review of our third quarter financial results.

2 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,079.57 -42.44 -0.25%
S&P 500 1,996.74 -3.38 -0.17%
NASDAQ 4,557.6950 -11.9260 -0.26%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs